新型1型糖尿病适应量表（DAS-1）的开发与初步验证
Development and Preliminary Validation of a New Type 1 Diabetes Adjustment Scale (DAS-1).
作者信息
Rivas Teresa, Carreira Mónica, Domínguez-López Marta, Ruiz de Adana Maria Soledad, Anarte María Teresa
机构信息
Department of Psychobiology and Behavioral Sciences Methodology, University of Málaga, Málaga, Spain.
Department of Personality, Assessment and Psychological Treatment, Institute of Biomedical Research of Malaga (IBIMA), University of Málaga, Málaga, Spain.
出版信息
Front Psychol. 2020 Apr 16;11:533. doi: 10.3389/fpsyg.2020.00533. eCollection 2020.
BACKGROUND
This study focuses on the development and validation of a new Type 1 Diabetes Adjustment Scale (DAS-1).
METHOD
A total of 204 participants aged 15-65 with type 1 diabetes completed the self-report measures of the DAS-1, which includes clinical and psychological variables.
RESULTS
Robust confirmatory factor analysis detected a unidimensional structure of the item scores. The omega coefficient was 0.91 and test-retest reliability was 0.87. Classifying subjects as in a Positive or Negative mood state, ROC analysis yielded an optimal cut-off of 50 for the DAS-1 scores, with a clinical accuracy of AUC = 0.85. The DAS-1 demonstrated evidence of good reliability and acceptable construct validity.
CONCLUSION
The DAS-1 demonstrated good clinical utility, good sensitivity and adequate specificity. Clinical and theoretical implications of these results are discussed.
背景
本研究聚焦于新型1型糖尿病适应量表（DAS - 1）的开发与验证。
方法
共有204名年龄在15 - 65岁的1型糖尿病患者完成了DAS - 1的自我报告测量，该量表涵盖临床和心理变量。
结果
稳健的验证性因素分析检测到项目得分的单维结构。欧米伽系数为0.91，重测信度为0.87。将受试者分为积极或消极情绪状态，ROC分析得出DAS - 1得分的最佳临界值为50，曲线下面积（AUC）的临床准确性为0.85。DAS - 1显示出良好的信度和可接受的结构效度证据。
结论
DAS - 1显示出良好的临床效用、良好的敏感性和足够的特异性。讨论了这些结果的临床和理论意义。
Zotero 插件